<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Troelsen | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/josephsort33/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/josephsort33/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Troelsen.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">eb954e3af7cf8ad10f58a89472bcf8d4</guid>
				<title>Troelsen posted an update: future directions in clinical and research contexts. [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42559/</link>
				<pubDate>Sun, 09 Feb 2025 09:58:47 -0800</pubDate>

									<content:encoded><![CDATA[<p>future directions in clinical and research contexts. Laryngoscope, 2020.Immunoglobulin G (IgG) is important in clearance and recognition of previously presented antigens and after activation, IgGs can interact with the Fc gamma receptors (FcγRs) on haematopoietic cells, including bone-resorbing osteoclasts. The pathogenicity of IgG, that is the&hellip;<span class="activity-read-more" id="activity-read-more-42559"><a href="http://www.nationalboardinstitute.com/activity/p/42559/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">30045cc6b22f90242a46fcd8a9a1f74b</guid>
				<title>Troelsen posted an update: 95 [22%] of 429 patients in the pembrolizumab plus axitinib [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39008/</link>
				<pubDate>Wed, 05 Feb 2025 09:57:30 -0800</pubDate>

									<content:encoded><![CDATA[<p>95 [22%] of 429 patients in the pembrolizumab plus axitinib group vs 84 [20%] of 425 patients in the sunitinib group), alanine aminotransferase increase (54 [13%] vs 11 [3%]), and diarrhoea (46 [11%] vs 23 [5%]). No new treatment-related deaths were reported since the first interim analysis.</p>
<p> With extended study follow-up, results from&hellip;<span class="activity-read-more" id="activity-read-more-39008"><a href="http://www.nationalboardinstitute.com/activity/p/39008/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">de8543aeab76e79e9bc1e305c8ea674d</guid>
				<title>Troelsen posted an update: Preoperative abnormal hyper-connectivity was normalized to [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37301/</link>
				<pubDate>Mon, 03 Feb 2025 09:51:50 -0800</pubDate>

									<content:encoded><![CDATA[<p>Preoperative abnormal hyper-connectivity was normalized to the control level after surgery. The postoperative hyperconnectivity was associated with long-term neurodevelopmental improvement.</p>
<p> PLI quantifies neurodevelopmental improvements after posterior quadrantectomy.</p>
<p>PLI quantifies neurodevelopmental improvements after posterior&hellip;<span class="activity-read-more" id="activity-read-more-37301"><a href="http://www.nationalboardinstitute.com/activity/p/37301/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3e0b97267a7a919e7d4524571f05fff5</guid>
				<title>Troelsen posted an update: Population density alone accounts for 57% of the variation [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35538/</link>
				<pubDate>Sat, 01 Feb 2025 09:56:25 -0800</pubDate>

									<content:encoded><![CDATA[<p>Population density alone accounts for 57% of the variation (R-squared) in the aspatial models and up to 76% in the spatial models. Adding the three population subgroup percentage variables raised the R-squared of the aspatial models to 72% and the spatial model to 84%. The influences of the three population subgroups were substantial, but changed&hellip;<span class="activity-read-more" id="activity-read-more-35538"><a href="http://www.nationalboardinstitute.com/activity/p/35538/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ae9a8e966adacb8d5bcb248fdb8c810f</guid>
				<title>Troelsen posted an update: Introduction Giant slalom is the core discipline of alpine [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33635/</link>
				<pubDate>Thu, 30 Jan 2025 10:00:39 -0800</pubDate>

									<content:encoded><![CDATA[<p>Introduction Giant slalom is the core discipline of alpine skiing, and each race has its own specific course and terrain characteristics. These variations may explain differences in the speed and time per turn profiles, which are essential for performance development and injury prevention. This study aims to address the differences in course&hellip;<span class="activity-read-more" id="activity-read-more-33635"><a href="http://www.nationalboardinstitute.com/activity/p/33635/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">93837bad3267238172a7e4b0acb46b64</guid>
				<title>Troelsen posted an update: 8%) CS patients having a prior history of mold exposure [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/27122/</link>
				<pubDate>Tue, 28 Jan 2025 08:47:35 -0800</pubDate>

									<content:encoded><![CDATA[<p>8%) CS patients having a prior history of mold exposure compared to 9 of 36 (25.0%) of the controls. After multivariable analysis, there remained significant associations between CS and smoking (odds ratio 0.14 [95% confidence interval 0.04-0.51], </p>
<p> = 0.002) and mold exposure (odds ratio 5.69 [95% confidence interval 1.68-19.25], </p>
<p> = 0.005).&hellip;<span class="activity-read-more" id="activity-read-more-27122"><a href="http://www.nationalboardinstitute.com/activity/p/27122/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9ecc782eafabce17293a59591d0e5bf1</guid>
				<title>Troelsen became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/27094/</link>
				<pubDate>Tue, 28 Jan 2025 08:46:04 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>